Israel
· Delayed Price · Currency is ILS · Price in ILAHuman Xtensions Statistics
Total Valuation
Human Xtensions has a market cap or net worth of ILS 12.39 million. The enterprise value is 1.07 million.
| Market Cap | 12.39M |
| Enterprise Value | 1.07M |
Important Dates
The next estimated earnings date is Thursday, November 21, 2024.
| Earnings Date | Nov 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Human Xtensions has 26.76 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Shares Outstanding | 26.76M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.27% |
| Owned by Institutions (%) | n/a |
| Float | 11.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.89 |
| PB Ratio | 0.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.04 |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.04 |
Financial Position
The company has a current ratio of 3.88, with a Debt / Equity ratio of 7.88.
| Current Ratio | 3.88 |
| Quick Ratio | 3.01 |
| Debt / Equity | 7.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.04 |
| Interest Coverage | -357.77 |
Financial Efficiency
Return on equity (ROE) is -107.00% and return on invested capital (ROIC) is -64.59%.
| Return on Equity (ROE) | -107.00% |
| Return on Assets (ROA) | -51.61% |
| Return on Capital (ROIC) | -64.59% |
| Revenue Per Employee | 50,500 |
| Profits Per Employee | -586,240 |
| Employee Count | 50 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.25% in the last 52 weeks. The beta is 1.49, so Human Xtensions's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -57.25% |
| 50-Day Moving Average | 43.51 |
| 200-Day Moving Average | 66.08 |
| Relative Strength Index (RSI) | 46.85 |
| Average Volume (20 Days) | 3,681 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Human Xtensions had revenue of ILS 2.53 million and -29.31 million in losses. Loss per share was -1.10.
| Revenue | 2.53M |
| Gross Profit | 1.46M |
| Operating Income | -30.05M |
| Pretax Income | -29.31M |
| Net Income | -29.31M |
| EBITDA | -29.68M |
| EBIT | -30.05M |
| Loss Per Share | -1.10 |
Balance Sheet
The company has 12.34 million in cash and 1.02 million in debt, giving a net cash position of 11.32 million or 0.42 per share.
| Cash & Cash Equivalents | 12.34M |
| Total Debt | 1.02M |
| Net Cash | 11.32M |
| Net Cash Per Share | 0.42 |
| Equity (Book Value) | 12.91M |
| Book Value Per Share | 0.48 |
| Working Capital | 13.55M |
Cash Flow
In the last 12 months, operating cash flow was -27.29 million and capital expenditures -26,000, giving a free cash flow of -27.31 million.
| Operating Cash Flow | -27.29M |
| Capital Expenditures | -26,000 |
| Free Cash Flow | -27.31M |
| FCF Per Share | -1.02 |
Margins
| Gross Margin | 57.62% |
| Operating Margin | -1,190.22% |
| Pretax Margin | -1,160.87% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,081.74% |
Dividends & Yields
Human Xtensions does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.51% |
| Shareholder Yield | 0.51% |
| Earnings Yield | -237.31% |
| FCF Yield | -220.49% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |